Advertisement

Topics

Search Results for "Biochemistry Leukemia"

06:40 EDT 30th May 2016 | BioPortfolio

Matching Channels

Chronic Leukemia

Chronic leukemia is a long term increase of abnormal white blood cells. It can be classed as myelogenous or lymphocytic leukemia. For more information see the Leukemia pages Add the Leukemia New...

Acute Leukemia

Acute leukemia occurs when a hematopoietic stem cell undergoes malignant transformation into a primitive, undifferentiated cell with abnormal longevity. These lymphocytes (acute lymphocytic leukemia...

Acute Myelocytic Leukemia AML

Acute myelocytic leukemia is a life-threatening disease in which the neutrophil, basophil, eosinophil, and monocyte precursors become cancerous and rapidly replace normal cells in the bone marrow. ...

Chronic Myelocytic Leukemia CML

Chronic myelocytic leukemia is the resulting disease when neutrophil, basophil, eosinophil, and monocyte progenitors become cancerous. It is usually caused by the presence of the Philadelphia chromo...

Acute Lymphocytic Leukemia ALL

Acute lymphocytic leukemia (ALL) is a life-threatening disease in which the cells that normally develop into lymphocytes become cancerous and rapidly replace normal cells in the bone marrow. ALL acc...

Matching News

#jobs #lifescience UNL Biochemistry Department: Two Postdoctoral Positions – University of Nebraska-Lincoln – Biochemistry Department

// Up to $49,999 + Specific Benefits: UNL Biochemistry Department: Two Postdoctoral Positions: 1) Lipid Metabolism and Small Molecule Analysis, 2) Bioreactor Design and Implementation #1 in America...

AbbVie Leukemia Drug Under Review

Venetoclax, a novel leukemia treatment developed by biopharmaceutical company AbbVie, is to be reviewed by regulators in the US and EU. The drug is described as a potential first-in-class therapy for ...

Scientists Identify Genes Critical to Leukemia

New research suggests that 2 genes involved in epigenetic programming may be attractive targets against acute myeloid leukemia (AML), the most common form of leukemia among adults (Cheung N et al. Can...

Early and Accurate Prediction of Leukemia Made Possible

Acute myeloid leukemia is the most common type of leukemia in adults and recent studies demonstrate that early and accurate...

#jobs #lifescience JRF position @ NIN Hyderabad | M.Sc Biotech | Biochemistry

// National Institute of Nutrition was established with a vision to enable food and nutrition security conducive to good health, growth The post JRF position @ NIN Hyderabad | M.Sc Biotech |...

Protein 'handbrake' halts leukemia in its tracks

(Walter and Eliza Hall Institute) Melbourne researchers have showed that they can stop leukemia in its tracks by targeting a protein that puts the handbrake on cancer cell growth.The researchers disco...

#jobs #lifescience MRC CASE PhD Studentship (Fixed Term) | Biochemistry

// Involvement of the small G protein regulated tyrosine kinase, ACK, in regulation of the PI3K signalling pathway. A fully funded The post MRC CASE PhD Studentship (Fixed Term) | Biochemistry ap...

Acute Leukemia Takeaways From ASH 2015: New Agents

Dr Farhad Ravandi provides an overview of the highlights in acute myeloid leukemia and acute lymphoblastic leukemia from the 2015 American Society of Hematology Annual Meeting. Medscape Oncology

Matching PubMed Articles

Ginsenoside Rh2 Mitigates Pediatric Leukemia Through Suppression of Bcl-2 in Leukemia Cells.

Acute myeloid leukemia (AML) is a severe malignant cancer worldwide, in both adult and pediatric patients. Since bone marrow cell transplantation is seriously limited by the availability of the immune...

Sumoylation of the Tumor Suppressor Promyelocytic Leukemia Protein Regulates Arsenic Trioxide-Induced Collagen Synthesis in Osteoblasts.

Promyelocytic leukemia (PML) protein is a tumor suppressor that fuses with retinoic acid receptor-α (PML-RARα) to contribute to the initiation of acute promyelocytic leukemia (APL). Arsenic trioxide...

PEITC in End-Stage B-Cell Prolymphocytic Leukemia: Case Report of Possible Sensitization to Salvage R-CHOP.

B-cell prolymphocytic leukemia (B-PLL) is a rare, aggressive leukemia distinct from chronic lymphocytic leukemia, with median survival of only 3 years. B-PLL is resistant to most chemotherapy and newe...

Cutaneous manifestations in leukemia patients.

Cutaneous complications are common in patients with leukemia. However, the cause is not always immediately clear, as there are often numerous potential etiologies. Thrombocytopenia or coagulopathy can...

Leukemia-free survival in myeloid leukemia, but not in lymphoid leukemia, is predicted by early CD4+ reconstitution following unrelated cord blood transplantation in children: a multicenter retrospective cohort analysis.

Search Whole site using Google

Loading
Quick Search
Advertisement
 
Advertisement Advertisement